Cite
Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion.
MLA
Pei-Jer Chen, et al. “Issues and Controversies of Hepatocellular Carcinoma-Targeted Therapy Clinical Trials in Asia: Experts’ Opinion.” Liver International, vol. 30, no. 10, Nov. 2010, pp. 1427–38. EBSCOhost, https://doi.org/10.1111/j.1478-3231.2010.02292.x.
APA
Pei-Jer Chen, Furuse, J., Kwang-Hyub Han, Chiun Hsu, Ho-Yeong Lim, HanLim Moon, Shukui Qin, Sheng-Long Ye, Ee-Min Yeoh, & Winnie Yeo. (2010). Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts’ opinion. Liver International, 30(10), 1427–1438. https://doi.org/10.1111/j.1478-3231.2010.02292.x
Chicago
Pei-Jer Chen, Junji Furuse, Kwang-Hyub Han, Chiun Hsu, Ho-Yeong Lim, HanLim Moon, Shukui Qin, Sheng-Long Ye, Ee-Min Yeoh, and Winnie Yeo. 2010. “Issues and Controversies of Hepatocellular Carcinoma-Targeted Therapy Clinical Trials in Asia: Experts’ Opinion.” Liver International 30 (10): 1427–38. doi:10.1111/j.1478-3231.2010.02292.x.